Retireful LLC’s AbbVie ABBV Stock Holding History

Retireful LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,145	Closed	-$398K	–	95
2025 Q2	$398K	Buy	2,145 +270	+14%	+$50.2K	0.27%	102
2025 Q1	$385K	Buy	+1,875	New	+$365K	0.36%	73

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Retireful LLC's ABBV Position: Q3 2025 in Review

Retireful LLC sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 2,145 shares — an estimated $398K sold.

Retireful LLC first reported a position in ABBV in Q1 2025 and held it in 2 quarters. The position peaked at $398K in Q2 2025. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

Retireful LLC reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
Retireful LLC sold 2,145 AbbVie shares in Q3 2025, an estimated $398K.
Retireful LLC first reported a position in AbbVie in Q1 2025 and held it in 2 quarters.
Retireful LLC's AbbVie position peaked at $398K in Q2 2025.
3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Retireful LLC's 13F filing for Q3 2025, filed 17 Oct 2025.